Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Non-equilibrium in the Cell01:16

Non-equilibrium in the Cell

4.8K
An important concept in studying metabolism and energy is that of chemical equilibrium. Most chemical reactions are reversible. They can proceed in both directions, releasing energy into their environment in one direction, and absorbing it from the environment in the other direction. The same is true for the chemical reactions involved in cell metabolism, such as the breaking down and building up of proteins into and from individual amino acids, respectively. Reactants within a closed system...
4.8K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Hematopoiesis01:21

Hematopoiesis

5.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.

Bone marrow transplantation·2026
Same author

Clinically Relevant Bleeding in Individuals With Cancer: Insights From a Nationwide Cohort Study.

American journal of hematology·2026
Same author

Artificial intelligence triage tool for bone marrow fibrosis in myeloproliferative neoplasms using complete blood counts.

The Lancet. Haematology·2026
Same author

JAKPOT Prediction Rule for Erythrocytosis: External Validation and Cost-Effectiveness Analysis.

American journal of hematology·2026
Same author

Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in <i>TP53</i>-Mutated Diffuse Large B-Cell Lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Bringing the Teaching Close to Home: Implementation of a Near-Peer Model for Introductory Hematology-Oncology Fellowship Lecture Series.

Journal of cancer education : the official journal of the American Association for Cancer Education·2026
Same journal

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

Blood·2026
Same journal

Identifying steroid-refractory aGVHD before it happens.

Blood·2026
Same journal

ELISA-negative HIT: antibody recognition and relevance.

Blood·2026
Same journal

EBV and immunodeficiency: the odd couple drawn to the brain.

Blood·2026
Same journal

A bone to pick with ferric carboxymaltose.

Blood·2026
Same journal

A step toward streamlining HIT diagnosis.

Blood·2026
See all related articles

Related Experiment Video

Updated: Sep 10, 2025

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence
09:11

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Published on: January 27, 2023

2.2K

Artificial intelligence in hematology.

Aziz Nazha1, Olivier Elemento2, Sanjay Ahuja3

  • 1Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.

Blood
|August 22, 2025
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) and machine learning (ML) offer transformative potential in hematology for improved diagnostics and personalized treatments. However, challenges in data quality, bias, and regulation currently limit widespread clinical adoption of these powerful tools.

More Related Videos

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

236
Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

1.7K

Related Experiment Videos

Last Updated: Sep 10, 2025

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence
09:11

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Published on: January 27, 2023

2.2K
Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

236
Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

1.7K

Area of Science:

  • Hematology
  • Artificial Intelligence (AI)
  • Machine Learning (ML)
  • Generative AI

Background:

  • Hematologic disorder diagnosis and treatment rely on integrating diverse data (imaging, pathology, omics, labs).
  • Increasing data volume and complexity challenge clinical decision-making.
  • AI/ML offer advanced modeling for enhanced diagnostic accuracy, risk stratification, and treatment prediction.

Purpose of the Study:

  • To review the current state of AI/ML in hematology as of 2025.
  • To identify existing gaps in AI/ML implementation in clinical practice.
  • To provide insights into future developments and applications of AI in hematology.

Main Methods:

  • Review of current literature and advancements in AI/ML within hematology.
  • Analysis of the impact of Generative AI on therapeutic strategies and diagnostic workflows.
  • Identification of challenges hindering clinical implementation of AI/ML tools.

Main Results:

  • AI/ML show significant potential for revolutionizing hematology, from diagnostics to personalized patient management.
  • Generative AI can enhance novel therapies, diagnostic image/report generation, and patient care personalization.
  • Limited clinical implementation is attributed to data quality, equity, infrastructure, and evaluation metric challenges.

Conclusions:

  • AI/ML, including Generative AI, represent a significant leap forward for hematology.
  • Critical challenges such as bias, data quality, and regulatory gaps impede widespread adoption.
  • Addressing these challenges is crucial for realizing the full potential of AI in clinical hematology.